Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A ...
Johnson & Johnson Launches "Dual Control" Campaign in Asia Pacific to Empower Patients with IBD to Balance Disease Management ...
With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...
The real-world effects of biologic therapy for inflammatory bowel disease (IBD) do not match the promising outcomes observed in randomized controlled trials, a study has shown. Rather than being a ...
SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed. Among ...
A Spanish trial finds similar sustained IBD clinical remission rates 1-year post-withdrawal vs maintenance of anti-TNF ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback